Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:53:13.630Z.
Calculation as of: 2026-10-06T19:53:13.630Z.
Quote observation: 2026-10-06T19:50:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
NOMAD Power Solutions, Inc.
Market Cap
$53.12M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $53.12M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $52.99M | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.71M | N/A |
| Aldeyra The (ALDX)vs › | $54.46M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | N/A |
| ImageneBio Inc (IMA)vs › | $51.55M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.99M | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.66M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.59M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
